We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+6.4%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$575M
AUM Growth
+$25.5M
(+4.6%)
Cap. Flow
-$9.13M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
68.14%
Holding
91
New
5
Increased
34
Reduced
36
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$1.08M |
| 2 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$856K |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$805K |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$476K |
| 5 |
Vanguard Information Technology ETF
VGT
|
+$457K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$3.23M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$3.17M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$2.03M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.58M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$1.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.85% |
| 2 | Technology | 2.82% |
| 3 | Consumer Discretionary | 0.77% |
| 4 | Communication Services | 0.57% |
| 5 | Consumer Staples | 0.36% |
Similar funds
MBA
SIA
AP
MW
SBIA
LC
TW
PAME
Callan Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Callan Capital held 91 positions worth $575M, up 4.6% from $550M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Callan Capital's Q2 2021 filing shows 5 new, 34 increased, 36 reduced and 2 closed positions. Its largest new stake was Infinity Pharmaceuticals, Inc.: 121,800 shares worth $364K. The largest sale was Invesco FTSE RAFI US 1000 ETF, an estimated $3.23M.
By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 95% a quarter earlier, followed by Technology and Consumer Discretionary.
- Callan Capital's largest Q2 2021 buy was Infinity Pharmaceuticals, Inc.: 121,800 shares worth $364K.
- Callan Capital added most to Goldman Sachs ActiveBeta International Equity ETF in Q2 2021, an estimated $1.08M increase.
- Callan Capital's biggest Q2 2021 reduction was Invesco FTSE RAFI US 1000 ETF, cutting an estimated $3.23M.
- Callan Capital fully exited Uber in Q2 2021, selling an estimated $296K.
- Callan Capital's ten largest holdings make up 68% of its $575M portfolio in Q2 2021.
- Callan Capital opened 5 new positions and closed 2 in Q2 2021.
- Callan Capital's portfolio value rose 4.6% quarter-over-quarter to $575M.
Based on Callan Capital's 13F filing for Q2 2021, filed 10 Aug 2021.